Maxime Esvan
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Pharmacology top 10%
- Pharmaceutical industry and healthcare
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 4
-
- Childhood Cancer Survivors' Quality of Life 2
- Co-authors
- Maxime Ronot (4 shared papers)Valérie Vilgrain (4 shared papers)Christophe Aube (4 shared papers)Gilles Châtellier (1 shared paper)Aurore Caumont‐Prim (1 shared paper)Jerome Lebigot (2 shared papers)Bruno Laviolle (5 shared papers)Anthony Chapron (4 shared papers)
- Journals
- Anesthesiology (3 papers)Pediatric Blood & Cancer (2 papers)Intensive Care Medicine (2 papers)Blood (1 paper)BMC Cancer (1 paper)
- Partner nations
- FranceUnited States
In The Last Decade
Maxime Esvan
47 papers receiving 1.1k citations
Maxime Esvan's Hit Papers
Peers
Comparison fields: 5 of 64
- Hepatology 151
- Pharmacology 42
- Anesthesiology and Pain Medicine 26
- Radiology, Nuclear Medicine and Imaging 81
- Surgery 153
Countries citing papers authored by Maxime Esvan
This map shows the geographic impact of Maxime Esvan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxime Esvan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxime Esvan more than expected).
Fields of papers citing papers by Maxime Esvan
This network shows the impact of papers produced by Maxime Esvan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxime Esvan. The network helps show where Maxime Esvan may publish in the future.
Co-authors
The 25 scholars most cited alongside Maxime Esvan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Balanced Opioid-free Anesthesia with Dexmedetomidine versus Balanced Anesthesia with Remifentanil for Major or Intermediate Noncardiac Surgery Hit paper breakdown → | 2021 | 217 |
| 2 | 2016 | 126 | |
| 3 | 2017 | 106 | |
| 4 | 2017 | 98 | |
| 5 | 2022 | 69 | |
| 6 | 2022 | 53 | |
| 7 | 2019 | 50 | |
| 8 | 2016 | 48 | |
| 9 | 2018 | 33 | |
| 10 | 2020 | 29 | |
| 11 | 2012 | 23 | |
| 12 | 2016 | 23 | |
| 13 | 2022 | 23 | |
| 14 | 2020 | 17 | |
| 15 | 2020 | 15 | |
| 16 | 2012 | 14 | |
| 17 | 2020 | 14 | |
| 18 | 2018 | 13 | |
| 19 | 2016 | 11 | |
| 20 | 2017 | 11 |
About Maxime Esvan
Maxime Esvan is a scholar working on Hepatology, Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health, Pharmacology and Nutrition and Dietetics, having authored 52 papers that have together received 1.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Childhood Cancer Survivors' Quality of Life (2 papers), HIV/AIDS Research and Interventions (2 papers), Reproductive Health and Contraception (2 papers), Mechanical Circulatory Support Devices (2 papers), Nutrition and Health in Aging (2 papers), Pharmaceutical industry and healthcare (2 papers) and Respiratory Support and Mechanisms (2 papers). The work is most often cited by research in Hepatology (151 citations), Pharmacology (42 citations), Anesthesiology and Pain Medicine (26 citations), Radiology, Nuclear Medicine and Imaging (81 citations) and Surgery (153 citations). Maxime Esvan has collaborated with scholars based in France and United States. Frequent co-authors include Maxime Ronot, Valérie Vilgrain, Christophe Aube, Gilles Châtellier, Aurore Caumont‐Prim, Jerome Lebigot, Bruno Laviolle, Anthony Chapron, Ronan Thibault and Benjamin Bastian. Their work appears in journals such as Anesthesiology, Pediatric Blood & Cancer, Intensive Care Medicine, Blood and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.